Severe GI adverse reactions Severe GI adverse reactions have been reported in patients receiving Wegovy
Tirzepatide is a compound that closely mimics these hormone receptors and speeds up the brains response to food
For instance, if you reconstitute a 12 mg vial with 2.4 mL of BAC water, the concentration becomes 5 mg per mL
Framing non-approved medications as automatically unsafe ignores that all currently approved medications were once non-approved medications working through the same process
[1] [4] These drugs include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist
Studies were not designed to systematically assess blood pressure and randomization was not stratified based on baseline status of hypertension, SBP and other relevant parameters that could have affected the outcomes